43871-Yeh, Elizabeth

Elizabeth S. Yeh, PhD

Associate Professor of Pharmacology & Toxicology

Vice Chair for Research

Phone
(317) 274-7828
Address
MS A519
PHTX
IN
Indianapolis, IN
PubMed:

Bio

Dr. Elizabeth Yeh received a PhD in Pharmacology from Duke University where she studied cellular transformation in order to understand how normal cells become cancerous. Dr. Yeh went on to do a postdoctoral fellowship in Cancer Biology at the University of Pennsylvania. Her postdoctoral research focused on protein kinase signaling and in vivo modeling of breast cancer. From 2013-2019, Dr. Yeh was a facutly member in the Department of Cell and Molecular Pharmacology and Experimental Therapeutics at the Medical University of South Carolina. In 2019, she joined the faculty in the Department of Pharmacology and Toxicology at Indiana University. Research in the Yeh Lab focuses on breast cancer biology and Alzheimer's disease with expertise in experimental therapeutics. 

Key Publications

Ramos Solis, N, Cannon, A, Dilday, T, Abt, M, Oblak, AL, Soloff, AC, Kaplan, M, and Yeh, ES. (2024) HUNK as a Key Regulator of Tumor Associated Macrophages in Triple Negative Breast Cancer. OncoImmunology 13(1):2364382. doi: 10.1080/2162402X.2024.2364382

Dilday, T, Abt, M, Ramos Solis, N, Dayal, N, Larocque, E, Oblak, AL, Sandusky, GE, Sintim, HO, and Yeh, ES. (2024) Identification and Characterization of a Potent and Selective HUNK Inhibitor for Treatment of HER2+ Breast Cancer. Cell Chem Biol. S2451-9456(24)00037-0. doi: 10.1016/j.chembiol.2024.01.001. 

Baker, K.M.; Abt, M.; Doud, E.H.; Oblak, A.L.; Yeh, ES. (2024) Mapping the Anti-Cancer Activity of α-Connexin Carboxyl-Terminal (aCT1) Peptide in Resistant HER2+ Breast Cancer. Cancers, 16, 423. doi: 10.3390/cancers16020423

 

Research Labs

Faculty research at IU School of Medicine is transforming health. Details about the medical research being conducted in faculty labs throughout IU School of Medicine are available in the Research section of this site.